Statistics

Total Visits

Views
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: Efficacy and cardiac safety from the GEICAM/2004-05 study38

Select a period of time:

Number of views in the range

Views
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: Efficacy and cardiac safety from the GEICAM/2004-05 study25

Views

Views
October 20241
November 20241
December 20241
January 20250
February 20255
March 202516
April 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States3
United Kingdom2
Germany2
Spain1
 

Top cities views

Views
Buffalo1